Searched for
UGUR SAHIN
Could cancer vaccines become a reality? Here’s what experts sayA cancer vaccine could be a reality in a few years, according to the co-founders of BioNTech, a German company, which also manufactured the...- Amid Covid vaccine success, BioNTech plans to return €2bn to shareholdersAfter the success of the covid vaccine, BioNTech is planning to return €2bn to shareholders. BioNTech will continue the clinical trial to b...
- Pfizer-BioNTech begin trials of new vaccine against Omicron variantThe study will have 1420 subjects, with three cohorts examining different regimens of the current Pfizer-BioNTech COVID vaccine or an Omicr...
- BioNTech says three month interval between second and third COVID-19 shots warrantedChief Executive Officer Ugur Sahin said new data would prompt a discussion about bringing the third shot of its currently available vaccine...
- BioNTech CEO says current vaccine likely to protect against severe COVID from OmicronLab tests are underway over the next two weeks to analyse the blood of people who had two or three doses of BioNTech's Comirnaty vaccine to...
- BioNTech says repeats of its COVID-19 vaccine better than devising new one, for nowThe German biotech firm said that offering a third dose of its established two-shot vaccine remained the best response to concerns over wan...
- No need yet to adapt Pfizer vaccine for coronavirus variants, says BioNTech chiefA decision to make a switch should be made only if it is clear that the vaccine failed to work or is only offering sub-par protection again...
- BioNTech CEO says vaccine up to 75% effective against India variantWHO's regional director said on Thursday COVID-19 vaccines being deployed in Europe, including that of Pfizer-BioNTech, appear able to prot...
- Vaccine maker BioNTech says no need to waive patentsUgur Sahin, the chief executive of BioNTech, rejected the U.S.-backed proposal to temporarily lift some intellectual property rights for va...
- BioNTech to build mRNA manufacturing site in SingaporeThe biotech company said the Singapore production facility will have an estimated annual capacity of several hundred million doses of mRNA-...
- Europe will reach herd immunity this summer: BioNTech bossWhile the exact threshold required to reach that critical level of immunization remains a matter of debate, experts say a level above 70% w...
- BioNTech co-founder 'confident' vaccine works against Indian variant"We are still testing the Indian variant, but the Indian variant has mutations that we have already tested for and which our vaccine works ...
- Pfizer vaccine appears effective against coronavirus variant found in Britain: StudyThe encouraging results from an analysis of blood of participants in trials are based on more extensive analysis than those released by the...
- BioNTech founders warn of vaccine supply gapsThe delays in rolling out the home-grown vaccine have caused consternation in Germany, where some regions had to halt vaccinations within d...
- Covid virus will stay with us for next 10 years: BioNTech CEOIn a virtual press conference this week, Sahin spoke about the potential virus deadline when asked when life could return to normal.
- BioNTech says can make mutation-beating vaccine in six weeks"Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variant," said Ugur Sahin.
- BioNTech confident COVID-19 vaccine effective against new UK mutationCountries across the globe shut their borders to Britain on Monday due to fears about a highly infectious new coronavirus strain, causing t...
- With US now in hand, Germany's BioNTech CEO looks for more vaccine production"The baseline plan is 1.3 billion doses," Sahin said. "And we are working on an extended plan. I can't tell you at the moment what is possi...
- The understated husband-and-wife 'dream team' behind Pfizer's coronavirus vaccinePfizer and BioNTech are the first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine. The compan...
- Behind Pfizer's vaccine, an understated husband-and-wife 'dream team'Pfizer said on Monday said its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large s...
Load More
